Agilon Health (NYSE:AGL) Trading 6.8% Higher – Time to Buy?

Agilon Health, Inc. (NYSE:AGL)’s share price rose 6.8% during mid-day trading on Wednesday . The company traded as high as $115.56 and last traded at $114.76. Approximately 101,823 shares were traded during mid-day trading, a decline of 71% from the average session volume of 350,864 shares. The stock had previously closed at $107.47.

Analysts Set New Price Targets

AGL has been the subject of a number of recent research reports. Benchmark reaffirmed a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Robert W. Baird raised their price target on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a research report on Monday, May 4th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $58.73.

Agilon Health Stock Up 7.3%

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The stock has a 50-day simple moving average of $87.34 and a 200-day simple moving average of $42.03. The company has a market cap of $1.92 billion, a price-to-earnings ratio of -5.31 and a beta of 2.98.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, analysts predict that Agilon Health, Inc. will post -3.5 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its position in shares of Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares in the last quarter. AQR Capital Management LLC raised its stake in Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after purchasing an additional 9,505,837 shares during the period. North Peak Capital Management LLC lifted its stake in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after acquiring an additional 3,715,460 shares in the last quarter. Voleon Capital Management LP grew its stake in Agilon Health by 5,519.2% during the 3rd quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after acquiring an additional 2,692,259 shares in the last quarter. Finally, UBS Group AG increased its holdings in shares of Agilon Health by 250.7% in the 4th quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock valued at $2,339,000 after purchasing an additional 2,427,136 shares during the period.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.